Details of the Drug

General Information of Drug (ID: DM5JCNQ)

• Drug Name: ICON-1

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]

• Cross-matching ID: TTD ID: D0H6UL

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)